Showing results (1461-1470 of 1,703) with videos related to

Sort By:
Pageof 171
Cardiovascular Research|May 31, 2008
A review of methods for assessment of coronary microvascular disease in both clinical and experimental settingsAxel R Pries, Helmut Habazettl, Giuseppe Ambrosio, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 21, 2023
Characteristics of de novo cancer in liver transplant recipientsTine Holm Riis, Dina Leth Møller, Julie Høgh, et al.
European Heart Journal Open|November 27, 2025
Characteristics, trends, and outcomes of ablation for persistent atrial fibrillation: a Danish cohort studyLise Da Riis-Vestergaard, Jacob Tønnesen, Martin H Ruwald, et al.
British Journal of Clinical Pharmacology|December 15, 2010
Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide studyDitte-Marie Bretler, Peter Riis Hansen, Steen Zabell Abildstrøm, et al.
Neurobiology of Disease|March 5, 2018
Inflammation kinase PKR phosphorylates α-synuclein and causes α-synuclein-dependent cell deathLasse Reimer, Louise Buur Vesterager, Cristine Betzer, et al.
Ugeskrift for Laeger|April 19, 2012
[Obese pregnant women and complications in relation to pregnancy and birth]Christina Anne Vinter, Mette Honnens Tanvig, Peter Damm, et al.
Clinical Endocrinology|August 11, 2025
Canadian Endocrinologists' Perspectives on Treatment With Thyroid Hormone Substitutions in Euthyroid and Hypothyroid Patients: A 2023 THESIS Questionnaire SurveyAnna Liu, Deric Morrison, Laszlo Hegedüs, et al.
ACS Applied Materials & Interfaces|November 24, 2020
Engineering Dielectric Screening for Potential-well Arrays of Excitons in 2D MaterialsNamphung Peimyoo, Hsin-Yu Wu, Janire Escolar, et al.
Environmental Science & Technology|February 21, 2008
Characterization and quantification of pneumatic fracturing effects at a clay till siteCamilla Maymann Christiansen, Charlotte Riis, Stine B Christensen, et al.
Mayo Clinic Proceedings|February 6, 2017
Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis: Results of the ACTIVExtend TrialFelicia Cosman, Paul D Miller, Gregory C Williams, et al.
Pageof 171